International Clinical Trial: A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463183) titled 'A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Merck Sharp & Dohme LLC

Condition: Colitis Ulcerative Ulcerative Colitis

Intervention: Drug: MK-8690

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 30, 2026

Target Sample Size: 100

To know more, visit https://c...